Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 28-Mar-24 4:31 PM View:  | Johnston John Joseph Director | Maxcyte, Inc. (MXCT) | 26-Mar-24 | Planned Option Sale | 5,000 | $4.41 | $22,025.00 | (4%) 125.58K to 120.58K | |
| 28-Mar-24 4:31 PM View: | Johnston John Joseph Director | Maxcyte, Inc. (MXCT) | 26-Mar-24 | Option Exercise | 5,000 | $2.14 | $10,710.00 | 4% 120.58K to 125.58K | |
| 19-Mar-24 6:21 PM View: | Ross Thomas M. EVP, Global Sales & Marketing | Maxcyte, Inc. (MXCT) | 15-Mar-24 | Grant | 25,000 | -- | -- | 100% 0 to 25.0K | |
| 19-Mar-24 6:18 PM View: | Swirsky Douglas J Chief Financial Officer | Maxcyte, Inc. (MXCT) | 15-Mar-24 | Grant | 81,250 | -- | -- | 100% 0 to 81.25K | |
| 19-Mar-24 6:20 PM View: | Sandoval David I. General Counsel | Maxcyte, Inc. (MXCT) | 15-Mar-24 | Grant | 3,913 | -- | -- | 9% 42.0K to 45.91K | |
| 28-Feb-24 10:00 PM View: | Johnston John Joseph Director | Maxcyte, Inc. (MXCT) | 26-Feb-24 | Planned Option Sale | 5,000 | $4.60 | $23,005.00 | (4%) 125.58K to 120.58K | |
| 28-Feb-24 10:00 PM View: | Johnston John Joseph Director | Maxcyte, Inc. (MXCT) | 26-Feb-24 | Option Exercise | 5,000 | $2.14 | $10,710.00 | 4% 120.58K to 125.58K | |
| 30-Jan-24 4:30 PM View: | Johnston John Joseph Director | Maxcyte, Inc. (MXCT) | 26-Jan-24 | Option Exercise | 5,000 | $2.14 | $10,710.00 | 4% 120.58K to 125.58K | |
| 30-Jan-24 4:30 PM View: | Johnston John Joseph Director | Maxcyte, Inc. (MXCT) | 26-Jan-24 | Planned Option Sale | 5,000 | $5.12 | $25,585.00 | (4%) 125.58K to 120.58K | |
| 28-Dec-23 4:30 PM View: | Johnston John Joseph Director | Maxcyte, Inc. (MXCT) | 26-Dec-23 | Option Exercise | 5,000 | $2.14 | $10,710.00 | 4% 120.58K to 125.58K | |
| 28-Dec-23 4:30 PM View: | Johnston John Joseph Director | Maxcyte, Inc. (MXCT) | 26-Dec-23 | Planned Option Sale | 5,000 | $4.53 | $22,650.00 | (4%) 125.58K to 120.58K | |
| 06-Dec-23 4:15 PM View: | Doerfler Douglas President and CEO Director | Maxcyte, Inc. (MXCT) | 05-Dec-23 | Planned Option Sale | 99,442 | $5.17 | $514,115.00 | (23%) 432.64K to 333.2K | |
| 06-Dec-23 4:15 PM View: | Doerfler Douglas President and CEO Director | Maxcyte, Inc. (MXCT) | 05-Dec-23 | Option Exercise | 99,442 | $0.04 | $3,977.68 | 30% 333.2K to 432.64K | |
| 06-Dec-23 4:15 PM View: | Doerfler Douglas President and CEO Director | Maxcyte, Inc. (MXCT) | 04-Dec-23 | Option Exercise | 25,008 | $0.04 | $1,000.32 | 8% 333.2K to 358.2K | |
| 06-Dec-23 4:15 PM View: | Doerfler Douglas President and CEO Director | Maxcyte, Inc. (MXCT) | 04-Dec-23 | Planned Option Sale | 25,008 | $5.01 | $125,290.00 | (7%) 358.2K to 333.2K | |
| 01-Dec-23 5:14 PM View: | Doerfler Douglas President and CEO Director | Maxcyte, Inc. (MXCT) | 01-Dec-23 | Option Exercise | 20,200 | $0.04 | $808.00 | 6% 333.2K to 353.4K | |
| 01-Dec-23 5:14 PM View: | Doerfler Douglas President and CEO Director | Maxcyte, Inc. (MXCT) | 01-Dec-23 | Planned Option Sale | 20,200 | $5.00 | $101,000.00 | (6%) 353.4K to 333.2K | |
| 01-Dec-23 5:14 PM View: | Doerfler Douglas President and CEO Director | Maxcyte, Inc. (MXCT) | 29-Nov-23 | Planned Option Sale | 5,350 | $5.00 | $26,750.00 | (2%) 338.55K to 333.2K | |
| 01-Dec-23 5:14 PM View: | Doerfler Douglas President and CEO Director | Maxcyte, Inc. (MXCT) | 29-Nov-23 | Option Exercise | 5,350 | $0.04 | $214.00 | 2% 333.2K to 338.55K | |
| 29-Nov-23 4:36 PM View: | Johnston John Joseph Director | Maxcyte, Inc. (MXCT) | 27-Nov-23 | Planned Option Sale | 5,000 | $4.59 | $22,950.00 | (4%) 125.58K to 120.58K | |
| 29-Nov-23 4:36 PM View: | Johnston John Joseph Director | Maxcyte, Inc. (MXCT) | 27-Nov-23 | Option Exercise | 5,000 | $2.14 | $10,710.00 | 4% 120.58K to 125.58K | |
| 16-Nov-23 4:48 PM View: | Johnston John Joseph Director | Maxcyte, Inc. (MXCT) | 14-Nov-23 | Option Exercise | 10,000 | $1.71 | $17,052.80 | 8% 120.58K to 130.58K | |
| 16-Nov-23 4:48 PM View: | Johnston John Joseph Director | Maxcyte, Inc. (MXCT) | 14-Nov-23 | Planned Option Sale | 10,000 | $3.71 | $37,100.00 | (8%) 130.58K to 120.58K | |
| 30-Aug-23 5:22 PM View: | Johnston John Joseph Director | Maxcyte, Inc. (MXCT) | 30-Aug-23 | Option Exercise | 2,841 | $1.64 | $4,662.08 | 2% 120.58K to 123.42K | |
| 30-Aug-23 5:22 PM View: | Johnston John Joseph Director | Maxcyte, Inc. (MXCT) | 30-Aug-23 | Planned Option Sale | 2,841 | $3.70 | $10,511.70 | (2%) 123.42K to 120.58K | |
| 30-Aug-23 5:22 PM View: | Johnston John Joseph Director | Maxcyte, Inc. (MXCT) | 29-Aug-23 | Option Exercise | 2,059 | $1.64 | $3,378.82 | 2% 120.58K to 122.64K | |
| 30-Aug-23 5:22 PM View: | Johnston John Joseph Director | Maxcyte, Inc. (MXCT) | 29-Aug-23 | Planned Option Sale | 2,059 | $3.70 | $7,618.30 | (2%) 122.64K to 120.58K | |
| 30-Aug-23 5:22 PM View: | Johnston John Joseph Director | Maxcyte, Inc. (MXCT) | 28-Aug-23 | Option Exercise | 100 | $1.64 | $164.10 | < 1% 120.58K to 120.68K | |
| 30-Aug-23 5:22 PM View: | Johnston John Joseph Director | Maxcyte, Inc. (MXCT) | 28-Aug-23 | Planned Option Sale | 100 | $3.70 | $370.00 | (< 1%) 120.68K to 120.58K | |
| 28-Jul-23 4:30 PM View: | Johnston John Joseph Director | Maxcyte, Inc. (MXCT) | 26-Jul-23 | Option Exercise | 5,000 | $1.64 | $8,205.00 | 4% 120.58K to 125.58K | |
| 28-Jul-23 4:30 PM View: | Johnston John Joseph Director | Maxcyte, Inc. (MXCT) | 26-Jul-23 | Planned Option Sale | 5,000 | $4.75 | $23,750.00 | (4%) 125.58K to 120.58K | |
| 12-Jul-23 6:06 PM View: | Doerfler Douglas President and CEO Director | Maxcyte, Inc. (MXCT) | 12-Jul-23 | Planned Option Sale | 16,757 | $5.02 | $84,120.10 | (5%) 349.95K to 333.2K | |
| 12-Jul-23 6:06 PM View: | Doerfler Douglas President and CEO Director | Maxcyte, Inc. (MXCT) | 12-Jul-23 | Option Exercise | 16,757 | $0.04 | $670.28 | 5% 333.2K to 349.95K | |
| 12-Jul-23 6:06 PM View: | Doerfler Douglas President and CEO Director | Maxcyte, Inc. (MXCT) | 11-Jul-23 | Planned Option Sale | 12,798 | $5.04 | $64,501.90 | (4%) 346.0K to 333.2K | |
| 12-Jul-23 6:06 PM View: | Doerfler Douglas President and CEO Director | Maxcyte, Inc. (MXCT) | 11-Jul-23 | Option Exercise | 12,798 | $0.04 | $511.92 | 4% 333.2K to 346.0K | |
| 12-Jul-23 6:06 PM View: | Doerfler Douglas President and CEO Director | Maxcyte, Inc. (MXCT) | 10-Jul-23 | Planned Option Sale | 445 | $5.01 | $2,229.45 | (< 1%) 333.64K to 333.2K | |
| 12-Jul-23 6:06 PM View: | Doerfler Douglas President and CEO Director | Maxcyte, Inc. (MXCT) | 10-Jul-23 | Option Exercise | 445 | $0.04 | $17.80 | < 1% 333.2K to 333.64K | |
| 28-Jun-23 5:05 PM View: | Johnston John Joseph Director | Maxcyte, Inc. (MXCT) | 27-Jun-23 | Option Exercise | 7,471 | $1.64 | $12,259.90 | 6% 120.58K to 128.05K | |
| 28-Jun-23 5:05 PM View: | Johnston John Joseph Director | Maxcyte, Inc. (MXCT) | 27-Jun-23 | Planned Option Sale | 7,471 | $4.39 | $32,797.70 | (6%) 128.05K to 120.58K | |
| 28-Jun-23 5:05 PM View: | Johnston John Joseph Director | Maxcyte, Inc. (MXCT) | 26-Jun-23 | Option Exercise | 7,529 | $1.05 | $7,869.50 | 6% 120.58K to 128.11K | |
| 28-Jun-23 5:05 PM View: | Johnston John Joseph Director | Maxcyte, Inc. (MXCT) | 26-Jun-23 | Planned Option Sale | 7,529 | $4.49 | $33,805.20 | (6%) 128.11K to 120.58K | |
| 15-Jun-23 4:30 PM View: | Doerfler Douglas President and CEO Director | Maxcyte, Inc. (MXCT) | 14-Jun-23 | Planned Option Sale | 28,883 | $5.04 | $145,570.00 | (8%) 362.08K to 333.2K | |
| 15-Jun-23 4:30 PM View: | Doerfler Douglas President and CEO Director | Maxcyte, Inc. (MXCT) | 14-Jun-23 | Option Exercise | 28,883 | $0.04 | $1,155.32 | 9% 333.2K to 362.08K | |
| 15-Jun-23 4:30 PM View: | Doerfler Douglas President and CEO Director | Maxcyte, Inc. (MXCT) | 13-Jun-23 | Option Exercise | 14,968 | $0.04 | $598.72 | 4% 333.2K to 348.17K | |
| 15-Jun-23 4:30 PM View: | Doerfler Douglas President and CEO Director | Maxcyte, Inc. (MXCT) | 13-Jun-23 | Planned Option Sale | 14,968 | $5.03 | $75,289.00 | (4%) 348.17K to 333.2K | |
| 05-May-23 5:09 PM View: | Doerfler Douglas President and CEO Director | Maxcyte, Inc. (MXCT) | 03-May-23 | Option Exercise | 16,149 | $0.04 | $645.96 | 5% 333.2K to 349.35K | |
| 05-May-23 5:09 PM View: | Doerfler Douglas President and CEO Director | Maxcyte, Inc. (MXCT) | 03-May-23 | Planned Option Sale | 16,149 | $5.02 | $81,068.00 | (5%) 349.35K to 333.2K | |
| 12-Apr-23 5:03 PM View: | Ross Thomas M. EVP, Global Sales & Marketing | Maxcyte, Inc. (MXCT) | 12-Apr-23 | Option Exercise | 5,583 | $2.14 | $11,958.80 | 100% 0 to 5.58K | |
| 12-Apr-23 4:37 PM View: | Doerfler Douglas President and CEO Director | Maxcyte, Inc. (MXCT) | 12-Apr-23 | Planned Option Sale | 12,718 | $5.00 | $63,590.00 | (4%) 345.92K to 333.2K | |
| 12-Apr-23 5:03 PM View: | Ross Thomas M. EVP, Global Sales & Marketing | Maxcyte, Inc. (MXCT) | 12-Apr-23 | Planned Option Sale | 5,583 | $5.00 | $27,915.00 | (100%) 5.58K to 0 |
